Design Therapeutics, Inc.
DSGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$50 | -$67 | -$63 | -$36 |
| Dep. & Amort. | -$6 | $1 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | -$0 |
| Stock-Based Comp. | $13 | $13 | $11 | $5 |
| Change in WC | -$1 | $1 | $2 | $1 |
| Other Non-Cash | $0 | -$6 | -$1 | $0 |
| Operating Cash Flow | -$43 | -$59 | -$51 | -$29 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$230 | -$225 | -$313 | -$86 |
| Inv. Sales/Matur. | $274 | $277 | $93 | $34 |
| Other Inv. Act. | $0 | $0 | $0 | -$0 |
| Investing Cash Flow | $44 | $53 | -$221 | -$54 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1 | $1 | $1 | $254 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$0 | $125 |
| Financing Cash Flow | $1 | $1 | $0 | $379 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1 | -$5 | -$272 | $296 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21 | $27 | $299 | $2 |
| End Cash | $23 | $21 | $27 | $299 |
| Free Cash Flow | -$43 | -$59 | -$52 | -$31 |